References
- Ader DN, Shriver CD. Cyclical mastalgia: prevalence and impact in an outpatient breast clinic sample. J Am Coll Surg 1997; 185: 466–70
- Smith RL, Pruthi S, Fitzpatrick LA. Evaluation and management of breast pain. Mayo Clin Proc 2004; 79: 353–72
- BeLieu RM. Mastodynia. Obstet Gynecol Clin North Am 1994; 21: 461–7
- Kontostolis E, Stefanidis K, Navrozoglou I, Lolis D. Comparison of tamoxifen with danazol for treatment of cyclical mastalgia. Gynecol Endocrinol 1997; 11: 393–7
- Oksa S, Luukkaala T, Mäenpää J. Toremifene for premenstrual mastalgia: a randomised, placebo-controlled crossover study. BJOG 2006; 113: 1–6
- Tajima C. Luteotropic effects of tamoxifen in infertile women. Fertil Steril 1984; 42: 223–7
- Oksa S, Luukkaala T, Mäenpää J. The antioestrogen toremifene has luteotropic effects in women suffering from premenstrual mastalgia. Acta Endocrinol 2008; 4: 425–32
- Leach MO. Breast cancer screening in women at high risk using MRI. NMR Biomed 2009; 22: 17–27
- Partridge SC. Future applications and innovations of clinical breast magnetic resonance imaging. Top Magn Reson Imaging 2008; 19: 171–6
- Eng-Wong J, Orzano-Birgani J, Chow CK, Venzon D, Yao J, Galbo CE, et al. Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 1696–701
- American College of Radiology. Breast imaging reporting and data system atlas (BI-RADS atlas). Reston, VA: American College of Radiology; 2003.
- Salokangas RKR, Poutanen O, Stengard E. Screening for depression in primary care. Development and validation of the Depression Scale, a screening instrument for depression. Acta Psychiatr Scand 1995; 92: 10–6
- Fowler PA, Casey CE, Cameron GG, Foster MA, Knight CH. Cyclic changes in composition and volume of the breast during the menstrual cycle, measured by magnetic resonance imaging. Br J Obstet Gynaecol 1990; 97: 595–602
- Hussain, Z, Roberts, N, Whitehouse, GH, García-Fiñana, Percy, D. Estimation of breast volume and its variation during the menstrual cycle using MRI and stereology. Br J Radiol 1999;72:236–45.
- Kuhl CK, Bieling HB, Gieseke J, Kreft BP, Sommer T, Lutterberg G, et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: Normal contrast medium enhancement and cyclical-phase dependency. Radiology 1997; 203: 137–44
- Delille J-P, Slanetz PJ, Yeh ED, Kopans DB, Garrido L. Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue. Breast J 2005; 11: 236–41
- Heywang-Köbrunner SH, Viehweg P, Heinig A, Küchler C. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 1997; 24: 94–108
- Cuzick J, Forbes J, Edwards R, Baum R, Cawthorn S, Coates A, et al. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 2002; 360: 817–24
- Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW. Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 2004; 96: 621–8